Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms 2Prostatic Neoplasms 1Prostatic Hyperplasia 1Prostatic Diseases 1Pain 1Lymphoma, Non-Hodgkin 1Leukemia 1Anxiety Disorders 1

Interventions

Rituximab 5Cyclophosphamide 3pirtobrutinib 2pegfilgrastim 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Drug Therapy 2Doxorubicin 2temsirolimus 1plerixafor 1pegylated granulocyte colony-stimulating factor 1ledipasvir, sofosbuvir drug combination 1ibrutinib 1ibritumomab tiuxetan 1fludarabine phosphate 1entecavir 1Vincristine 1Valsartan 1Thiotepa 1Tenofovir 1Sofosbuvir 1Ribavirin 1Radiotherapy 1Prilocaine 1Prednisone 1Oxygen 1Ifosfamide 1Fibroblast Growth Factor 7 1Dexamethasone 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Lymphoma, Non-Hodgkin × Oxygen × Clear all
NCT00808171 2014-07-29

Evaluation of the Analgesy With Emla and/or Nitrous Oxide in Pediatric Patients for Lumbar Puncture

Federal University of Minas Gerais

Phase 4 Completed
52 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡